Wafik S. El-Deiry: 2nd annual Legorreta Cancer Center translational oncology symposium
Wafik S. El-Deiry shared a post on LinkedIn:
“Group photo at 2nd annual Legorreta Cancer Center translational oncology symposium organized by Sendurai Mani at Legorreta Cancer Center at Brown University.
We are grateful to all of our speakers for joining us at Brown University for a wonderful event with true interdisciplinary exchange of information and discussion yesterday.
Great science, collegiality and wonderful spending time with our distinguished guests at Legorreta Cancer Center at Brown University.”
Source: Wafik S. El-Deiry/LinkedIn
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023